So what you are saying is the FDA is also a SCAM because they didn't give BMSN a refuse to file (RTF) status to their IND but assigned them a IND number??? That is why Koos acquired a $20M funding for the clinical trial and an additional 800M shares, as these will be need to acquire those fundings....and no the $100M+ cost is for phase II and III so part of the Regen BioPharma business model is to sell this IND/patent for $100M+ after phase I or continue with it to get annual revenue of $1B+ (but this will take time and they will need to spend $100M+ in cost....do your DD first.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.